PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Al-Dawaa Medical Services Company

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (5)

Compared with Healthcare companies in Saudi Arabia.

P/E ratio

16.1

Investors pay 16.1 for every 1 of Al-Dawaa Medical Services Company's yearly profit, higher than 62% of Healthcare companies in Saudi Arabia.

P/B ratio

2.18

The share price is 2.18 times Al-Dawaa Medical Services Company's book value per share, higher than 62% of Healthcare companies in Saudi Arabia.

Market cap

SAR 2.9 B

The total market value of all of Al-Dawaa Medical Services Company's shares at today's price (share price × number of shares), smaller than 79% of Healthcare companies in Saudi Arabia. PosiCap size class: Mini Cap.

Return on equity (ROE)

12.7%

Al-Dawaa Medical Services Company earned 12.7% on its shareholders' money over the last year, lower than 68% of Healthcare companies in Saudi Arabia.

Dividend yield

7.28%

Al-Dawaa Medical Services Company pays 7.28% of its share price as dividends a year, higher than 96% of dividend-paying Healthcare companies in Saudi Arabia.

Questions

What is Al-Dawaa Medical Services Company's P/E ratio?

Investors pay 16.1 for every 1 of Al-Dawaa Medical Services Company's yearly profit, higher than 62% of Healthcare companies in Saudi Arabia.

What is Al-Dawaa Medical Services Company's return on equity?

Al-Dawaa Medical Services Company earned 12.7% on its shareholders' money over the last year, lower than 68% of Healthcare companies in Saudi Arabia.

Does Al-Dawaa Medical Services Company pay a dividend?

Yes. Al-Dawaa Medical Services Company pays 7.28% of its share price as dividends a year, higher than 96% of dividend-paying Healthcare companies in Saudi Arabia.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.